Choriomon is a pharmaceutical preparation containing human chorionic gonadotrophin (hCG), i.e. the natural placental hormone.
The hormone hCG is used in a variety of clinical situations including the management of pregnancy miscarriage, the induction of final maturation as conclusion of follicle stimulation cycles and in long-term substitution therapy in hypogonadic men.
Choriomon is manufactured in Switzerland by virtue of a high tech process that results in a highly purified preparation with negligible content of contaminating proteins. Due to its level of purity, Choriomon may be administered subcutaneously .
Choriomon is available in vials of 2.000 or 5.000 I.U. and is intended for administration under strict medical control.

The advantages of Choriomon may be summarised as follows:

• High purity, which turns in improved safety and efficacy·
• Reliability, meaning consistency between labelled and actual content·
• Batch-to-batch consistency, ensuring that there are no changes from a production batch to another·
• Subcutaneous self-administration·
• Affordable cost, comparable to that of old-generation, non-highly purified products

The product information included in this web page is intended as a general presentation of the product and should not be used as instruction for use.
For full information please consult the summary of product characteristics as approved in your country.